83763-24-0 Usage
Uses
Used in Medical Applications:
N,N-dimethyl-4-phenylpiperidine-4-carboxamide monohydrochloride is used as a local anesthetic and analgesic for its pain-relieving properties. It is employed in medical settings to numb and reduce pain during various procedures.
Used in Neurological Disorder Treatment:
N,N-dimethyl-4-phenylpiperidine-4-carboxamide monohydrochloride is being investigated for its potential use in treating various neurological disorders. Its ability to block sodium channels may offer therapeutic benefits for conditions involving abnormal nerve function or pain.
It should be noted that N,N-dimethyl-4-phenylpiperidine-4-carboxamide monohydrochloride should be handled with care and used under the supervision of a healthcare professional due to its potent effects and potential side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 83763-24-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,7,6 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 83763-24:
(7*8)+(6*3)+(5*7)+(4*6)+(3*3)+(2*2)+(1*4)=150
150 % 10 = 0
So 83763-24-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O/c1-16(2)13(17)14(8-10-15-11-9-14)12-6-4-3-5-7-12/h3-7,15H,8-11H2,1-2H3
83763-24-0Relevant academic research and scientific papers
Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use
-
, (2008/06/13)
Compounds of the formula and quaternary ammonium ions thereof, wherein R1 and R2 are the same or different and are carbocyclic aryl or aromatic heterocyclic; A is methylene, carbonyl or sulfonyl; B is a single bond, C1-C4 alkylene or C2-C4, alkenylene; D is oxygen; E is C2 alkylene; G is C1-C4 alkylene or C2-C4 alkenylene; and L is -C(R4)(R5), wherein R4 and R5 together with the carbon atom to which they are attached represent a C5-C10 cycloalkyl or a C5-C10 heterocyclic. Especially preferred are compounds wherein L represents wherein J is a C1-C6 alkylene; Ar is a ring carbocyclic or aromatic heterocyclic and S*->O is a sulfoxide in which the sulfur atom is in the 5-configuration. The compounds have tachykinin receptor antagonist activity and exhibit an activity against both the NK1 and NK2 receptors.
